SCHEMBL7984480

SCHEMBL7984480

O=c1[nH]c(-c2ccccc2F)nc2ncn(CCOc3ccccc3)c12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNOT7 Q9UIV1 1/20 0.47
MAPK1 P28482 2/20 0.41
LMNA P02545 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.40
SMN1; SMN2 Q16637 4/20 0.39
KMT2A Q03164 3/20 0.39
MEN1 O00255 1/20 0.39
HPGD P15428 1/20 0.39
PDE5A O76074 1/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
ALOX15 P16050 1/20 0.39
HSD17B10 Q99714 1/20 0.39
ATM Q13315 1/20 0.39
LTA4H P09960 1/20 0.39
RXFP1 Q9HBX9 1/20 0.38
ALDH1A1 P00352 1/20 0.38
PDE1A P54750 1/20 0.37
PDE1B Q01064 1/20 0.37
PDE1C Q14123 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7985444 0.95 CNOT7 (0.41) CNOT7MAPK1LMNAL3MBTL1SMN1; SMN2
SCHEMBL7974274 0.85 CNOT7 (0.45) CNOT7MAPK1LMNASMN1; SMN2KMT2A
SCHEMBL7984486 0.83 CNOT7 (0.54) CNOT7MAPK1LMNAL3MBTL1SMN1; SMN2
SCHEMBL7984463 0.83 KDM4E (0.53) CNOT7MAPK1LMNASMN1; SMN2KMT2A
SCHEMBL7974644 0.82 SMN1; SMN2 (0.55) CNOT7SMN1; SMN2KMT2AMEN1HPGD
SCHEMBL7973916 0.80 LMNA (0.43) LMNASMN1; SMN2KMT2AMEN1HPGD
SCHEMBL7988183 0.78 SMN1; SMN2 (0.48) LMNAL3MBTL1SMN1; SMN2KMT2AMEN1
SCHEMBL7985867 0.78 GAA (0.53) LMNASMN1; SMN2KMT2AMEN1HPGD
SCHEMBL7985450 0.78 CNOT7 (0.48) CNOT7LMNASMN1; SMN2NPC1RAB9A
SCHEMBL7985770 0.78 CNOT7 (0.50) CNOT7MAPK1LMNAL3MBTL1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed